Physician profile
Alysha Poss
NPI 1902497423
$734.24
in general payments reported to CMS, 2019-2025
9 companies · $168 in 2025
The $168 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $207 · 2022: $87.73 · 2023: $139 · 2024: $133 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $195.05 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $176.24 | 2021-2024 | Lifevest |
| Medtronic, INC. | $138.90 | 2021-2025 | Micra, In.Pact Admiral, Hawkone |
| Shockwave Medical, INC | $88.01 | 2025 | |
| Irhythm Technologies, INC. | $36.47 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Inari Medical, INC. | $36.26 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Astrazeneca Pharmaceuticals LP | $25.72 | 2021 | |
| Alnylam Pharmaceuticals INC. | $18.84 | 2024 | Amvuttra |
| Kestra Medical Technology Services, INC. | $18.75 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alysha Poss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.